课题基金 / 基金详情

Synthesis of Peptide Isosteres with Strong Bombesin Antagonist Activity and Its Development to Anti-Cancer Agents

Synthesis of Peptide Isosteres with Strong Bombesin Antagonist Activity and Its Development to Anti-Cancer Agents
强铃蟾肽拮抗活性肽等排体的合成及其抗癌药物的开发
批准号:
08457621
负责人:
FUJII Nobutaka
金额:
$4.35万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

FUJII Nobutaka的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Among various dipeptide isosteres, the potential of (E)-alkene dipeptide isostsres (EADIs) as backbone replacement of amide bonds in peptides has been well documented in the past few years. However, the efficient stereocntrolled synthetic routes for EADIs have not been established. We previously reported the organocopper-mediated anti-S_N2' reactions of gamma, delta-cis-gamma, delta-eepimino-(E)-alpha, beta-enoates or gamma, delta-syn-delta-amino-gamma-mesyloxy-(E)-alpha, beta-enoates, which give L,L-type or L,D-type EADIs respectively. Based on the ab initio molecular orbital calculations, we have developed Pd(0)-catalyzed isomerization reactions of four diastereomixtures of gamma, delta-epimino-alpha, beta-enoates, easily prepared by the sequence of known reactions starting from L-amino acids, which give the desiarble key intermediates, gamma, delta-cis-gamma, delta-epimino-(E)-alpha, beta-enoates, in high yield. Furthermore, a brief treatment of the same substrates with dil. MeSO_3H quantitatively affords the regio-and stereoselectively ring-opened products, gamma, delta-syn-delta-amino-gamma-mesyloxy-(E)-alpha, beta-enoates. Essentially, in the same manner starting from D-amino acids, stereoselective synthesis of D,D-type and D,L-type EADIs is feasible. Thus, the totally stereocontrolled synthetic routes for four sets of homo chiral EADIs have been established.Application of the above straightforward synthetic strategy to derivatization of the potential peptide-lead anti-cancer compounds involving bombesin/GRP antagonist and Ras-Farnesyl transferase inhibitor has been examined.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Noda, et al.: "A Highlly Stereoselective Synthesis of the Functionalized(E)-Alkene Dipeptide Isosteres of Trp-Val via Organocyanocopper-Lewis Acid Mediated Reaction." Chem.Pharm.Bull.45(8). 1259-1264 (1997)
M.Noda 等人:“通过有机氰铜-路易斯酸介导的反应,高度立体选择性合成 Trp-Val 的官能化 (E)-烯烃二肽等排体。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Noda, et al.: "A Highly Stereoselective Synthesis of the Functionalized(E)-Alkene Dipeptide Isosters of Trp-Val via Organocyanocopper-Lewis Acid Mediated Reaction." Chem.Pharm.Bull.45(8). 1259-1264 (1997)
M.Noda 等人:“通过有机氰铜-路易斯酸介导的反应,高度立体选择性合成 Trp-Val 的功能化 (E)-烯烃二肽等排体。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Fujimoto, et al.: "Effects Structure Modification on Biological Activity of Bombesin Analogues with (E)-Alkene Bond." Life Sciences.60(1). 29-34 (1997)
K.Fujimoto 等人:“结构修饰对具有 (E)-烯烃键的铃蟾肽类似物的生物活性的影响”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
22
    Development and application of a novel screening technolgy toward effective uses of chemical library
    • 批准号:
      24659046
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      FUJII Nobutaka
    • 依托单位:
    Practical medicinal chemistry on the basis of protein chemistry, computational science and synthetic technologies for a variety of heterocycles
    • 批准号:
      23390025
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2011
    • 负责人:
      FUJII Nobutaka
    • 依托单位:
    Evolution of Drug Discovery Targeting for G-protein Coupled Receptors
    • 批准号:
      17209004
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $33.36万
    • 财政年份:
      2005
    • 负责人:
      FUJII Nobutaka
    • 依托单位:
    Genome/Proteome-lead Drug Discovery Based on Peptide/Protein Chemistry
    • 批准号:
      14207099
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.28万
    • 财政年份:
      2002
    • 负责人:
      FUJII Nobutaka
    • 依托单位: